This webpage contains legacy information. The product is either no longer available from the supplier or has been delisted at Labome.
product summary
company name :
Abnova
product type :
antibody
product name :
Pou5f1 polyclonal antibody
catalog :
PAB8880
quantity :
100 ug
clonality :
polyclonal
host :
domestic rabbit
conjugate :
nonconjugated
reactivity :
human, mouse, rat, bovine
application :
western blot, immunohistochemistry, immunoprecipitation
product information
catalog id :
PAB8880
product name :
Pou5f1 polyclonal antibody
product description :
Rabbit polyclonal antibody raised against synthetic peptide of Pou5f1.
gene name :
Pou5f1
gene alias :
Oct-3 Oct-3/4 Oct-4 Oct3 Oct3/4 Oct4 Otf-3 Otf-4 Otf3 Otf3-rs7 Otf3g Otf4
gene description :
POU domain, class 5, transcription factor 1
immunogen :
A synthetic peptide corresponding to N-terminus of mouse Pou5f1.
form :
Liquid
recommend dilutions :
Western Blot (0.5-4 ug/mL). Immunoprecipitation (20 ug/mL). Immunohistochemistry (20 ug/mL). The optimal working dilution should be determined by the end user.
storage buffer :
In PBS, pH 7.2 (30% glycerol, 0.5 mg/mL BSA, 0.01% thimerosal)
storage instruction :
Store at -20 C. For long term storage store at -80 C. Aliquot to avoid repeated freezing and thawing.
quality control testing :
Antibody Reactive Against Synthetic Peptide.
note :
This product contains thimerosal: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
type clonality :
Antibody
raised in host species :
Rabbit
antigen species target species :
Mouse
specificity :
This antibody reacts with 45 KDa Oct-4 (also designated Oct-3A) and in a less extent 33 KDa Oct-3B.
species reactivity cross reactivity :
Bovine,Human,Mouse,Pig,Rat
application key :
IP,IHC,WB-Ti
size :
100 ug
autodate :
2009-05-01
updatetime :
2011-11-01 10:56:20
company information

Abnova
9th Fl., No.108, Jhouzih St.
Neihu District. Taipei City
114 Taiwan
Neihu District. Taipei City
114 Taiwan
sales@abnova.com
https://www.abnova.com877-853-6098
questions and comments